Anant Labs

Lapatinib

CAS 231277-92-2

Overview

Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer

Anant Labs manufacture and furnish high quality Lapatinib impurities for global markets. Our Lapatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Lapatinib

Lapatinib

In Stock
CAS
231277-92-2
Mol. Formula
C29H26ClFN4O4S
Mol. Weight
581.069

Impurities (3)

Chemical structure of Lapatinib Ditosylate Monohydrate
Impurity

Lapatinib Ditosylate Monohydrate

In Stock
Cat. No.
ANT-LPT-003
CAS
388082-78-8
Mol. Formula
C43H44ClFN4O11S3
Mol. Weight
943.494
Chemical structure of Lapatinib Genotoxic Impurity 2
Impurity

Lapatinib Genotoxic Impurity 2

In Stock
Cat. No.
ANT-LPT-001
CAS
443882-99-3
Mol. Formula
C13H9ClFNO3
Mol. Weight
281.67
Chemical structure of Lapatinib Impurity 19
Impurity

Lapatinib Impurity 19

In Stock
Cat. No.
ANT-LPT-002
CAS
202197-26-0
Mol. Formula
C13H11ClFNO
Mol. Weight
251.68